Bivalacqua Trinity J, Champion Hunter C, Lambert David G, Kadowitz Philip J
Department of Pharmacology, Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USA.
Am J Physiol Regul Integr Comp Physiol. 2002 Jun;282(6):R1696-709. doi: 10.1152/ajpregu.00394.2001.
Hemodynamic responses to adenosine, the A(1) receptor agonists N(6)-cyclopentyladenosine (CPA) and adenosine amine congener (ADAC), and the A(2) receptor agonist 5'-(N-cyclopropyl)-carboxamido-adenosine (CPCA) were investigated in the hindquarter vascular bed of the cat under constant-flow conditions. Injections of adenosine, CPA, ADAC, CPCA, ATP, and adenosine 5'-O-(3-thiotriphosphate) (ATPgamma S) into the perfusion circuit induced dose-related decreases in perfusion pressure. Vasodilator responses to the A(1) agonists were reduced by the A(1) receptor antagonists KW-3902 and CGS-15943, whereas responses to CPCA were reduced by the A(2) antagonist KF-17837. Vasodilator responses to adenosine were reduced by KW-3902, CGS-15943, and by KF-17837, suggesting a role for both A(1) and A(2) receptors. Vasodilator responses to ATP and the nonhydrolyzable ATP analog ATP gamma S were not attenuated by CGS-15943 or KF-17837. After treatment with the nitric oxide synthase inhibitor N(omega)-nitro-L-arginine methyl ester, the cyclooxygenase inhibitor sodium meclofenamate, or the ATP-dependent K(+) (K) channel antagonists U-37883A or glibenclamide, responses to adenosine and ATP were not altered. Responses to adenosine, CPA, and CPCA were increased in duration by rolipram, a type 4 cAMP phosphodiesterase inhibitor, but were not altered by zaprinast, a type 5 cGMP phosphodiesterase inhibitor. When blood flow was interrupted for a 30-s period, the magnitude and duration of the reactive vasodilator response were reduced by A(1) and A(2) receptor antagonists. These data suggest that vasodilator responses to adenosine and the A(1) and A(2) agonists studied are not dependent on the release of cyclooxygenase products, nitric oxide, or the opening of K channels in the regional vascular bed of the cat. The present data suggest a role for cAMP in mediating responses to adenosine and suggest that vasodilator responses to adenosine and to reactive hyperemia are mediated in part by A(1) and A(2) receptors in the hindquarter vascular bed of the cat.
在恒流条件下,研究了猫后肢血管床对腺苷、A(1)受体激动剂N(6)-环戊基腺苷(CPA)和腺苷胺类似物(ADAC)以及A(2)受体激动剂5'-(N-环丙基)-甲酰胺基腺苷(CPCA)的血流动力学反应。向灌注回路中注射腺苷、CPA、ADAC、CPCA、ATP和腺苷5'-O-(3-硫代三磷酸)(ATPγS)可引起灌注压力呈剂量相关的下降。A(1)受体拮抗剂KW-3902和CGS-15943可降低对A(1)激动剂的血管舒张反应,而A(2)拮抗剂KF-17837可降低对CPCA的反应。KW-3902、CGS-15943和KF-17837均可降低对腺苷的血管舒张反应,提示A(1)和A(2)受体均起作用。CGS-15943或KF-17837不会减弱对ATP和不可水解的ATP类似物ATPγS的血管舒张反应。在用一氧化氮合酶抑制剂N(ω)-硝基-L-精氨酸甲酯、环氧化酶抑制剂甲氯芬那酸钠或ATP依赖性钾(K)通道拮抗剂U-37883A或格列本脲处理后,对腺苷和ATP的反应未改变。4型环磷酸腺苷磷酸二酯酶抑制剂咯利普兰可延长对腺苷、CPA和CPCA的反应持续时间,但5型环磷酸鸟苷磷酸二酯酶抑制剂扎普司特未改变这种反应。当血流中断30秒时,A(1)和A(2)受体拮抗剂可降低反应性血管舒张反应的幅度和持续时间。这些数据表明,对腺苷以及所研究的A(1)和A(2)激动剂的血管舒张反应不依赖于环氧化酶产物、一氧化氮的释放或猫局部血管床中钾通道的开放。目前的数据提示环磷酸腺苷在介导对腺苷的反应中起作用,并表明对腺苷和反应性充血的血管舒张反应部分由猫后肢血管床中的A(1)和A(2)受体介导。